首页 正文

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

{{output}}
Background: Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of th... ...